A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors

BACKGROUND: Modern therapies in oncology have increased cancer survivorship, as well as the incidence of cardiovascular adverse events. While immune checkpoint inhibitors have shown significant clinical impact in several cancer types, the incidence of immune-related cardiovascular (CV) adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Lal, Jessica Castrillon, Brown, Sherry-Ann, Collier, Patrick, Cheng, Feixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161966/
https://www.ncbi.nlm.nih.gov/pubmed/34049595
http://dx.doi.org/10.1186/s40959-021-00106-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161966/
https://www.ncbi.nlm.nih.gov/pubmed/34049595
http://dx.doi.org/10.1186/s40959-021-00106-x

Ejemplares similares